PG Insider Balaji Purushothaman Sells $672K of Stock

Key Points

  • Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, sold 4,181 shares at an average price of $160.71, reducing his total holdings to about 11,296 shares.
  • The stock closed at $161.02 on the day of the sale, and as of October 26, 2026, it was recently traded around $161.02.
  • Analysts have given the stock a consensus 'buy' rating with a mean price target of $172.35, indicating potential upside.

Get The Procter & Gamble Company text alerts

We text you when insiders, Congress, analysts or big funds move on $PG.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated The Procter & Gamble Company alert may contain errors. Disclosures

On October 23, 2026, Balaji Purushothaman, the Chief Human Resources Officer of The Procter & Gamble Company, sold 4,181 shares for $671,928. The sale was reported in a Form 4 filing with the SEC. After this transaction, Purushothaman holds about 11,296 shares, cutting his stake by 27.01%.

PG The Procter & Gamble Company
$161.02 +16.86% year to date
Daily close · Oct 23, 2026

Inside Balaji Purushothaman's Trade

Purushothaman sold the shares at an average price of $160.71. The total value of the transaction was $671,928. He did not indicate this was a planned sale.

Other Institutional Activity in Procter & Gamble

Several other funds also adjusted their positions in Procter & Gamble. NTV Asset Management increased its holdings by 8,824 shares, bringing its total to 39,756 shares worth about $5.8 million. Capital Investment Advisors added 17,061 shares, raising its stake to 462,434 shares valued at approximately $67.2 million. Meanwhile, Mutual of America Capital Management grew its position by 13,546 shares, totaling 253,659 shares worth about $36.9 million. In contrast, Penn Davis McFarland sold all of its shares, reducing its stake by 26,340 shares.

The Procter & Gamble Company Stock Down 2.1%

The stock closed at $161.02 on October 23, 2026. It has been trading recently around the same level, indicating stability. The shares are currently above their 50-day moving average by about 8.5% and the 200-day moving average by 8.4%. However, they are about 3.7% below the 52-week high of $167.25.

Recent Earnings

Procter & Gamble reported trailing twelve-month revenue of approximately $87.9 billion, with a net margin of 18.2% and a return on equity of 29.6%. The company is scheduled to report its next earnings on January 21, 2027.

Dividend

Procter & Gamble pays an annual dividend of $4.35 per share, which gives it a yield of 2.7%. The dividend payout ratio is 64.6%.

Insider Buying and Selling at The Procter & Gamble Company

In addition to Purushothaman's sale, other insiders also sold shares. Paul Gama, an officer, sold 2,225 shares on October 5, 2026, valued at $323,382. Another officer, Susan Street Whaley, sold 2,369 shares on the same day for $344,310. Additionally, Andre Schulten, the Chief Financial Officer, sold 3,914 shares for $568,861 on October 5, 2026. On the same day as Purushothaman's sale, Paul Gama sold 4,331 shares for $698,460.

Analysts Set New Price Targets

On October 23, 2026, several analysts updated their ratings on Procter & Gamble. Freedom Broker upgraded the stock to a 'Buy' rating with a target of $176. UBS maintained its 'Buy' rating but increased its target to $190. Citigroup also maintained a 'Buy' rating, raising its target to $187. BNP Paribas kept an 'Outperform' rating with a target of $189, while JP Morgan maintained an 'Overweight' rating with a target of $180. The consensus recommendation is 'Buy' with a mean price target of $172.35.

About Procter & Gamble

The Procter & Gamble Company provides a wide range of branded consumer goods globally, operating through five segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. This diverse portfolio helps the company maintain a strong market presence.

Bottom Line

Balaji Purushothaman's recent sale adds to a trend of insider selling at Procter & Gamble, which has seen multiple executives sell shares recently. Investors should watch for the upcoming earnings report on January 21, 2027, and any further insider transactions.

Source: Balaji Purushothaman's Form 4 filing on $PG (Oct 23, 2026). Written by software, not financial advice. How we make alerts

Get $PG trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions